Page last updated: 2024-08-18

pyrroles and Dermatofibrosarcoma

pyrroles has been researched along with Dermatofibrosarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ji, T; Ong, HS; Wang, LZ; Yu, ZW; Zhang, CP1
Blay, JY; Cassier, P; Dufresne, A; Heudel, P; Pissaloux, D; Ray-Coquard, I; Wang, Q1
Nishida, T1

Reviews

2 review(s) available for pyrroles and Dermatofibrosarcoma

ArticleYear
Dermatofibrosarcoma protuberans on the right neck with superior vena cava syndrome: case report and literature review.
    International journal of oral and maxillofacial surgery, 2013, Volume: 42, Issue:6

    Topics: Adult; Antineoplastic Agents; Dermatofibrosarcoma; Head and Neck Neoplasms; Humans; Indoles; Male; Neck; Neoplasm Recurrence, Local; Pyrroles; Sunitinib; Superior Vena Cava Syndrome; Thorax; Vena Cava, Superior

2013
[Molecular biology of sarcoma and therapeutic choices].
    Bulletin du cancer, 2015, Volume: 102, Issue:1

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzamides; Bone Neoplasms; Crizotinib; Denosumab; Dermatofibrosarcoma; Gastrointestinal Stromal Tumors; Gene Amplification; Gene Deletion; Giant Cell Tumor of Bone; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Phenylurea Compounds; Piperazines; Point Mutation; Prognosis; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sarcoma; Sarcoma, Ewing; Sunitinib; Synovitis, Pigmented Villonodular; Translocation, Genetic

2015

Other Studies

1 other study(ies) available for pyrroles and Dermatofibrosarcoma

ArticleYear
[Imatinib . Sunitinib].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8

    Topics: Angiogenesis Inhibitors; Benzamides; Carcinoma, Renal Cell; Dermatofibrosarcoma; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms; Sunitinib; Survival Rate

2007